Pathway point | Condition | Unscheduled care: indicator definition | Marginal effect (ME) | Std. Error |
---|---|---|---|---|
Arrival (Test) | HF | Evaluation of LVS Function | 0.009 | −0.0262 |
Arrival (Test) | PN | Initial antibiotic selection for CAP in immunocompetent patients | 0.0593* | −0.029 |
Arrival (Test) | PN | Blood cultures in A&E before antibiotic administration | 0.1027* | −0.0507 |
Arrival (Prevention) | AMI | Aspirin at arrival | 0.0018 | −0.0144 |
Arrival (Prevention) | AMI | Fibrinolytic Therapy within 30 min of arrival | 0.0184 | −0.0954 |
Arrival (Prevention) | PN | Initial antibiotic within 6 h of arrival | −0.049 | −0.0332 |
Discharge | AMI | Adult smoking cessation advice | −0.1521** | −0.0561 |
Discharge | HF | Discharge instructions | −0.1530*** | −0.0394 |
Discharge | HF | Adult smoking cessation advice | −0.0849 | −0.1154 |
Discharge | PN | Adult smoking cessation advice | −0.1002 | −0.0554 |
Discharge | AMI | Aspirin prescribed at discharge | 0.0066 | −0.0124 |
Discharge | AMI | ACEI or ARB for LVSD | 0.026 | −0.0326 |
Discharge | HF | ACEI or ARB for LVSD | −0.0086 | −0.0395 |
Discharge | AMI | Beta blocker prescribed at discharge | −0.0026 | −0.0237 |